BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23867070)

  • 21. Impact of restricted amoxicillin/clavulanic acid use on Escherichia coli resistance--antibiotic DU90% profiles with bacterial resistance rates: a visual presentation.
    Mimica Matanovic S; Bergman U; Vukovic D; Wettermark B; Vlahovic-Palcevski V
    Int J Antimicrob Agents; 2010 Oct; 36(4):369-73. PubMed ID: 20688486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment.
    Ladirat SE; Schoterman MH; Rahaoui H; Mars M; Schuren FH; Gruppen H; Nauta A; Schols HA
    Br J Nutr; 2014 Aug; 112(4):536-46. PubMed ID: 24925303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ease-of-use protocol for the rapid detection of third-generation cephalosporin resistance in Enterobacteriaceae isolated from blood cultures using matrix-assisted laser desorption ionization-time-of-flight mass spectrometry.
    Foschi C; Compri M; Smirnova V; Denicolò A; Nardini P; Tamburini MV; Lombardo D; Landini MP; Ambretti S
    J Hosp Infect; 2016 Jun; 93(2):206-10. PubMed ID: 27105753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Activity of the amoxicillin-clavulanic acid (augmentin) combination on strains of hospital isolates].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J
    Pathol Biol (Paris); 1985 May; 33(5):301-8. PubMed ID: 3929215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of in vitro susceptibility testing results for amoxicillin-clavulanate and ampicillin-sulbactam using a panel of beta-lactamase-producing Enterobacteriaceae.
    Siu LK; Cheng WL; Ho PL; Ng WS; Chau PY; Lo JY
    APMIS; 1998 Sep; 106(9):917-20. PubMed ID: 9808419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
    Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
    Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
    Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D
    J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
    Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
    Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the similarity of antimicrobial resistance phenotypes among fecal Escherichia coli isolates from two aggregated occupational cohorts of humans versus swine using cluster analysis and multivariate statistics.
    Alali WQ; Scott HM; Norby B
    Prev Vet Med; 2010 Apr; 94(1-2):77-83. PubMed ID: 20022646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of a combination of amoxicillin and clavulanic acid and a combination of ticarcillin and clavulanic acid on 249 enterobacteria].
    Aubert G; Lallard P; Dorche G; Denis M
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):651-4. PubMed ID: 3054741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
    Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
    Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of CTX-M-14 and TEM-52 extended-spectrum beta-lactamases in fecal Escherichia coli isolates of captive ostrich in Portugal.
    Carneiro C; Araújo C; Gonçalves A; Vinué L; Somalo S; Ruiz E; Uliyakina I; Rodrigues J; Igrejas G; Poeta P; Torres C
    Foodborne Pathog Dis; 2010 Aug; 7(8):991-4. PubMed ID: 20367084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers.
    Ponte C; Gracia M; Giménez MJ; Aguilar L; Maín CM; Carpintero Y; Huelves L; Carcas A; del Prado G; Soriano F
    Clin Ther; 2005 Jul; 27(7):1043-9. PubMed ID: 16154483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.
    File TM; Garau J; Jacobs MR; Wynne B; Twynholm M; Berkowitz E
    Int J Antimicrob Agents; 2005 Feb; 25(2):110-9. PubMed ID: 15664480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phyloproteomics: species identification of Enterobacteriaceae using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Conway GC; Smole SC; Sarracino DA; Arbeit RD; Leopold PE
    J Mol Microbiol Biotechnol; 2001 Jan; 3(1):103-12. PubMed ID: 11200222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings.
    Duytschaever G; Huys G; Bekaert M; Boulanger L; De Boeck K; Vandamme P
    Appl Environ Microbiol; 2011 Nov; 77(22):8015-24. PubMed ID: 21926193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of amoxicillin-clavulanic acid on clinical scores, intestinal microbiome, and amoxicillin-resistant Escherichia coli in dogs with uncomplicated acute diarrhea.
    Werner M; Suchodolski JS; Straubinger RK; Wolf G; Steiner JM; Lidbury JA; Neuerer F; Hartmann K; Unterer S
    J Vet Intern Med; 2020 May; 34(3):1166-1176. PubMed ID: 32324947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined antibacterial activity of clavulanic acid with amoxicillin and ampicillin against Gram-negative strains].
    Mascellino MT; Prignano G; Lorenzi A; Iegri F; Martorano E; Catania S; Ginanni Corradini S
    Boll Ist Sieroter Milan; 1984; 63(5):447-52. PubMed ID: 6335660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of the impact of the administration of Amoxicillin and Algo-Bio
    Kouadio IK; Guessennd N; Dadié A; Koffi E; Dosso M
    J Glob Antimicrob Resist; 2018 Jun; 13():161-164. PubMed ID: 29366720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Errors of the agar diffusion method to predict Escherichia coli's susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid].
    Villar HE; Jugo MB; Fernández-Lausi A; Farinati AE
    Enferm Infecc Microbiol Clin; 1996 May; 14(5):308-10. PubMed ID: 8744371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.